December 2015

 

In this Supplement

DCB Comes of Age

Durable. Consistent. Safe.

Issue

Global
Supplement

US Supplement

Download a PDF of this supplement

IN.PACT SFA Trial: Overview of Study Design and 2-Year Clinical Outcomes

Sustained durability of IN.PACT™ Admiral™ DCB treatment effect with no late catch-up through 2 years.

By Peter A. Schneider, MD

The Role of Preclinical Data in Drug-Coated Balloon Therapy

Drs. Virmani and Granada explain the importance of preclinical data, discuss key parameters for evaluation, and review the science behind clinical performance.

With Renu Virmani, MD, and Juan F. Granada, MD, FACC

Perspectives on 2-Year Drug-Coated Balloon Data

A panel of experts discusses how the 2-year IN.PACT SFA and 1-year IN.PACT Global Study data affect decisions in real-world clinical practice.

With Marianne Brodmann, MD; John H. Rundback, MD, FAHA, FSVM, FSIR; Peter A. Schneider, MD; and Jos C. van den Berg, MD, PhD
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.